| Document |
Document Title |
|
WO/2024/083491A1 |
The invention relates to an oligosaccharide of formula I derived from rare sugars, wherein R, X and n have the meanings defined in the specification. The invention also relates to its process to obtain it and to its use as a prebiotic an...
|
|
WO/2024/086623A1 |
A method of separating and recovering a first carbohydrate from a feed solution comprising two or more carbohydrates and salts using a chromatography separation system which comprises one or more strong acid cation exchange resin, and re...
|
|
WO/2024/065048A1 |
The present disclosure relates to sweetened fibers, compositions thereof, and products comprising the sweetened fiber of the present disclosure, and uses thereof. The present disclosure also relates to methods of preparing the sweetened ...
|
|
WO/2024/062148A1 |
The present invention relates to a process for producing hemicellulose-derived products from a lignocellulose material, said process comprising an alkaline pretreatment of said lignocellulose material to produce a hydrolysable solid, and...
|
|
WO/2024/053574A1 |
[Problem] The present invention addresses the problem of providing a novel oligosaccharide that is a two-branched glycan that has an α2,6-sialic acid structure at the non-reducing end, a production method for the oligosaccharide, an int...
|
|
WO/2024/042235A1 |
The present disclosure relates to a method for producing oligosaccharides where the method combines a fermentation process and an enzymatic reaction in the medium of the fermentation, thereby enabling the formation of the oligosaccharide...
|
|
WO/2024/036637A1 |
The present invention relates to the field of biochemistry, and specifically to a preparation method for a sodium hyaluronate oligosaccharide composition. Further disclosed are a prepared composition and a use. The preparation method for...
|
|
WO/2024/014657A1 |
The present invention provides a method for producing D-allulose crystals, comprising the steps of adding D-allulose seed crystals to a D-allulose-containing stock solution, and then carrying out a crystallization reaction under a temper...
|
|
WO/2024/008701A1 |
The present invention relates to a method of removing calcium citrate from a liquid dairy stream. In particular, the present invention relates to a method of removing calcium citrate from a liquid dairy stream wherein the liquid dairy st...
|
|
WO/2024/003840A1 |
The present application relates to a process for producing glucose comprising reacting water and carbon from a carbon source in the presence of a melanin device, which comprises melanin and a substrate material (e.g., silica, plastic, or...
|
|
WO/2023/242192A1 |
The invention relates to a syrup comprising one or more cellooligosaccharides in dissolved form at an overall content of at least 10 wt.-%, preferably at least 12.5 wt.-%, more preferably at least 50 wt.-%, relative to the total weight o...
|
|
WO/2023/240111A1 |
The present invention provides modified sophorolipids of formula (I) that are more pH- and temperature-stable than its lactonic counterparts. Moreover, the compound has reduced HLB parameters, as well as improved wetting and solubilizati...
|
|
WO/2023/225364A1 |
The invention provides methods for glycosylation and preparation of compounds. The compounds include galactosylated, sialylated, fucosylated, and N-acetylglucosaminylated compounds from simple animal-derived, plant-derived, or microbe-de...
|
|
WO/2023/198436A2 |
Described herein are compound useful as sweet flavor modifiers. Ingestible compositions that include one or more of these compounds in combination with a natural or artificial sweetener are also described.
|
|
WO/2023/174422A1 |
The present invention belongs to the technical field of crystal products, and relates to high-purity crystalline D-tagatose, a composition comprising same, a method for preparing same, and use thereof. Specifically, the crystalline D-tag...
|
|
WO/2023/176952A1 |
The purpose of the present invention is to provide a means for controlling the proliferation of a bacterium in the intestine. Provided is a composition for controlling the proliferation of any one bacterium selected from the group consis...
|
|
WO/2023/176951A1 |
Provided is a means for controlling proliferation of Collinsella bacteria in the intestines. The present invention addresses the problem of providing a novel material that is capable of controlling proliferation of Collinsella bacteria. ...
|
|
WO/2023/176950A1 |
Provided is a means for controlling the proliferation of any one bacterium selected from the group consisting of a bacterium belonging to the genus Faecalibacterium, a bacterium belonging to the genus Akkermansia, a bacterium belonging t...
|
|
WO/2023/168607A1 |
A compound or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition thereof are provided, wherein the compound includes a retinoic acid conjugated with a carbohydrate. In addition, use of the compound or the pharma...
|
|
WO/2023/170250A1 |
The invention relates to an enzymatic process for the preparation and purification of lactulose starting from lactose using cellobiose-2-epimerase (EC 5.1.3.11) followed by converting lactose to monosaccharides using lactase (EC 3.2.1.10...
|
|
WO/2023/170426A1 |
A prebiotic oligosaccharide composition. The composition comprises oligosaccharide compounds, for example galactooligosaccharide compounds, which includes: (a) at least 8 wt% Gal-(β1-3)-Gal-(β1-4)-Xa; (b) at least 3 wt% Gal-(β1-3)-Gal...
|
|
WO/2023/147789A1 |
Disclosed in the present invention is a chemical synthesis method of chitosan oligosaccharide with a controllable polymerization degree, which belongs to the field of sugar chemistry. The method of the present invention comprises the fol...
|
|
WO/2023/135229A1 |
The present invention relates to a polypeptide with at least 85% sequence identity to SEQ ID NO: 1, as an endo-ß-1,4-xylanase (EC 3.2.1.8) having transglycosylation activity. Preferably, said polypeptide is obtained from Rhamnusium bico...
|
|
WO/2023/130594A1 |
The present invention relates to L-arabinose as well as a preparation and the use thereof. The L-arabinose and the preparation thereof are prepared by means of the following process: (1) dissolving an L-arabinose raw material in water, a...
|
|
WO/2023/123805A1 |
The present invention relates to a system for preparing refined xylose and fermentable sugar by using corn straw. The system comprises a premix tank, an alkali treatment tank, an acid hydrolysis tank, an enzymatic hydrolysis tank, a neut...
|
|
WO/2023/124706A1 |
The present application relates to the field of deep processing of dairy products, in particular to a method for preparing a milk oligosaccharide, a milk oligosaccharide powder prepared using same, and food. The preparation method compri...
|
|
WO/2023/125505A1 |
The present invention provides a method for preparing stachyose, which method belongs to the technical field of the production of carbohydrates. The method comprises: breaking the wall of Stachys affinis; subjecting the resulting wall-br...
|
|
WO/2023/118961A1 |
The present disclosure is directed toward drugs and toxins functionalized by at least one saccharide, sulfate or sulfonate; drug conjugates comprising said drugs or toxins and a cleavable linker; and targeted conjugates comprising said d...
|
|
WO/2023/116302A1 |
The present invention relates to a method for co-producing erythritol and arabinose from a xylose mother liquor. Xylose is separated by means of first chromatographic separation to obtain an extract solution and a raffinate, the extract ...
|
|
WO/2023/118187A1 |
The present invention relates to a process for preparing a dried carbohydrate preparation from a water-containing crystalline carbohydrate starting preparation and carbohydrate particles, and to the carbohydrate preparation prepared by t...
|
|
WO/2023/119199A1 |
The present invention relates to a method for producing a nonfat milk solid extract on an industrial scale from a source of lactose, wherein the source of lactose is subjected to a pre-concentration, hydrolysis, pasteurisation, concentra...
|
|
WO/2023/114315A1 |
The invention provides methods and compositions for treating a parasitic infection in an animal.
|
|
WO/2023/093337A1 |
The present invention discloses a genetically engineered bacteria, which is E. coli integrated with lysogenic λDE3, and lacZ gene is completely inactivated, but does not affect exogenous protein expression of the genetically engineered ...
|
|
WO/2023/083977A1 |
The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a...
|
|
WO/2023/070223A1 |
The invention provides for a vaccine against S. suis serotype 2. The vaccine comprises chemically synthesized fragments and thus may be made widely commercially available. The vaccine is used in the livestock production and may be adapte...
|
|
WO/2023/069858A1 |
Methods for controlled synthesis and chemical recycling of stereoregular polysaccharides via polymerization of biomass-derived anhydrosugars are provided. The anhydrosugars react with an initiator in the presence of a synergy of a cataly...
|
|
WO/2023/066907A1 |
A method for providing a solid amorphous HMO product, said method including drying an aqueous composition of said HMO. Solid amorphous HMO product is obtained via said method, as well as solid amorphous HMO product per se.
|
|
WO/2023/063364A1 |
The purpose of the present invention is to provide a technology useful for sugar synthesis, the technology using formaldehyde as the main raw material and allowing for selective promotion of the formose reaction. This method for produc...
|
|
WO/2023/064751A1 |
The present invention relates to an enzymatic process for elongating gluco-oligosaccharides with a glucosyl moiety. The invention also relates to the elongated gluco-oligosaccharides obtained with the process. These elongated gluco-oligo...
|
|
WO/2023/039293A9 |
Provided herein are coumarin derivatives of sugar analogs which are used to measure the rate of hydrolysis of these sugar analogs when contacted with a glycosidase. The reactivity of the coumarin derivatives serves as a convenient method...
|
|
WO/2023/059530A1 |
Aspects of the disclosure relate to methods of using oligosaccharide compositions as microbiome metabolic therapies for treating inflammatory lung diseases and disorders, such as chronic obstructive pulmonary disease (COPD) and asthma.
|
|
WO/2023/049853A1 |
The present invention features compositions and methods for the repair of myelin and/or treatment of demyelinating diseases. The demyelinating disease may be multiple sclerosis (MS), optic neuritis, myelin oligodendrocyte glycoprotein an...
|
|
WO/2023/038517A1 |
The invention relates to a saponin derivative based on a saponin comprising a triterpene aglycone and at least one of a first saccharide chain and a second saccharide chain linked to the aglycone core structure, wherein the saponin deriv...
|
|
WO/2023/028377A1 |
Disclosed are co-solvents as well as methods of using thereof in oil and gas operations. Described herein are also methods of displacing an unrefined petroleum material in contact with a solid material, said method comprising: contacting...
|
|
WO/2023/018345A1 |
The invention relates to a method of producing an agent for purifying wastewater from municipal purification plants and from the chemical, food and livestock industries. The invention makes it possible to increase the degree of purificat...
|
|
WO/2023/014927A1 |
Disclosed herein are prodrugs of tapinarof and pharmaceutical formulations comprising tarpinarof, such as oral formulations. Further disclosed herein are methods for treating diseases and disorders of the gastrointestinal tract, skin, ey...
|
|
WO/2023/010010A1 |
Compositions, methods, systems and equipment capable of significantly reducing glyphosate, microbial, mycotoxin and other contaminant levels in various food commodities, such as, but not limited to, grains (e.g., corn, wheat, oats barley...
|
|
WO/2023/002354A1 |
The present invention relates to new synthetic molecules with agonist activity of human Toll-like Receptor 4 (TLR4), compositions comprising them and uses thereof for the treatment of diseases in which it is useful to induce or increase ...
|
|
WO/2023/002452A1 |
The present application provides synthetic processes for preparing N-acetyl-galactosamines (NAG) based compounds for targeted drug delivery. Also disclosed are Poly-NAG compounds, intermediates and targeting ligands, which are used and/o...
|
|
WO/2023/284848A1 |
The present invention relates to the field of biotechnology, and specifically discloses fructooligosaccharide having high kestose content and an application thereof. In the fructooligosaccharide having high kestose content in the present...
|
